Skip to main content
Year archive

AFT Pharmaceuticals Limited — 2022 filings

All 28 regulatory filings released by AFT Pharmaceuticals Limited (AFT) in 2022, sourced directly from the official regulator.

28 Filings
2022 Period
2022 filings (28)
Filing Released Lang
221124 Interim results FY23H1 App 2 amended
Interim / Quarterly Report
2022-11-23 English
AFT extends growth investment as sales surge
Interim / Quarterly Report
2022-11-23 English
AFT to announce half year interim results on Nov 24
Report Publication Announcement
2022-10-10 English
AFT update on Maxigesic IV(R) US registration filing
Regulatory Filings
2022-09-01 English
AFT collaborates to develop birthmark medicine
Capital/Financing Update
2022-08-31 English
Results of 2022 Annual Shareholder Meeting
Declaration of Voting Results & Voting Rights Announcements
2022-08-05 English
AFT 2022 ASM chairman’s address and presentation
AGM Information
2022-08-04 English
AFT Completes Pascomer Clinical Study and Takes Back Rights
Capital/Financing Update
2022-07-26 English
Dr Doug Wilson to step down from AFT Board
Board/Management Information
2022-07-21 English
AFT and RooLife launch OTC medicines online in China
Regulatory Filings
2022-07-06 English
Notice of Annual Meeting of Shareholders 2022
AGM Information
2022-07-04 English
US FDA seeks more information on Maxigesic IV(R) application
Regulatory Filings
2022-07-01 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2022-06-20 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2022-06-20 English
Annual Meeting and Closing Date for Director Nominations
AGM Information
2022-05-29 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2022-05-26 English
Annual Report revision
Annual Report
2022-05-23 English
AFT full year results FY2022
Annual Report
2022-05-22 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2022-05-11 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2022-05-05 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2022-05-05 English
AFT to announce full year results on Monday May 23 2022
Report Publication Announcement
2022-05-03 English
Capital Change Notice – Issue of ordinary shares
Share Issue/Capital Change
2022-04-28 English
AFT prevails in comparative advertising judgement
Regulatory Filings
2022-04-07 English
AFT notes FDA approval for Pascomer alternative
Capital/Financing Update
2022-04-05 English
ASX farmaforce release on contract sales force partnership
Regulatory Filings
2022-02-22 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2022-01-13 English
2022 New Year letter to investors
Investor Presentation
2022-01-07 English